Benjamin Edwards Inc Organon & Co. Transaction History

Benjamin Edwards Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$10.95 - $17.32 $251 - $398	23 Added 766.67%	26 $0
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $33 - $47	2 Added 200.0%	3 $0
Q2 2023 Aug 15, 2023	SELL	$19.27 - $24.63 $154 - $197	-8 Reduced 88.89%	1 $0
Q1 2023 Apr 27, 2023	SELL	$21.42 - $32.08 $342 - $513	-16 Reduced 64.0%	9 $0
Q4 2022 Feb 07, 2023	SELL	$23.31 - $28.61 $46 - $57	-2 Reduced 7.41%	25 $1,000
Q3 2022 Oct 28, 2022	SELL	$23.4 - $34.25 $959 - $1,404	-41 Reduced 60.29%	27 $1,000
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $1,234 - $1,517	-39 Reduced 36.45%	68 $2,000
Q1 2022 May 04, 2022	SELL	$30.45 - $39.36 $578 - $747	-19 Reduced 15.08%	107 $4,000
Q4 2021 Feb 07, 2022	BUY	$28.67 - $37.13 $2,895 - $3,750	101 Added 404.0%	126 $4,000
Q3 2021 Nov 02, 2021	BUY	$28.63 - $35.64 $715 - $891	25 New	25 $1,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

Stay updated on Benjamin Edwards Inc with notifications on news.